These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15456624)

  • 1. A prospective safety study of allergen immunotherapy in daily clinical practice.
    Iglesias-Cadarso A; Hernández-Weigand P; Reaño M; Herrera I; Sánchez-Morillas L; Pérez-Pimiento A
    Allergol Immunopathol (Madr); 2004; 32(5):278-83. PubMed ID: 15456624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists].
    Larenas Linnemann D; Rodríguez Pérez N; Becerril M
    Rev Alerg Mex; 2008; 55(2):62-70. PubMed ID: 19058483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.
    Rodríguez Del Río P; Vidal C; Just J; Tabar AI; Sanchez-Machin I; Eberle P; Borja J; Bubel P; Pfaar O; Demoly P; Calderón MA
    Pediatr Allergy Immunol; 2017 Feb; 28(1):60-70. PubMed ID: 27637414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on safty of standardized specific mite-allergen immunotherapy to children with allergic rhinitis and/or asthma].
    Wu Y; Long Z; Huang Y; Huang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(14):641-4. PubMed ID: 22032122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate adverse reactions to immunotherapy.
    Can D; Demir E; Tanaç R; Gülen F; Yenigün A
    J Investig Allergol Clin Immunol; 2003; 13(3):177-80. PubMed ID: 14635467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy.
    Bernstein DI; Epstein TEG
    Allergy Asthma Proc; 2020 Mar; 41(2):108-111. PubMed ID: 32122446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bee and bee products allergy in Turkish beekeepers: determination of risk factors for systemic reactions.
    Celikel S; Karakaya G; Yurtsever N; Sorkun K; Kalyoncu AF
    Allergol Immunopathol (Madr); 2006; 34(5):180-4. PubMed ID: 17064646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous Immunotherapy Safety: Incidence per Surveys and Risk Factors.
    Sánchez-Borges M; Bernstein DI; Calabria C
    Immunol Allergy Clin North Am; 2020 Feb; 40(1):25-39. PubMed ID: 31761119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease].
    Molina-Sáenz MM; Villa-Arango AM; Cardona-Villa R
    Rev Alerg Mex; 2017; 64(1):52-65. PubMed ID: 28188713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of adverse reactions induced by subcutaneous immunotherapy against dust mite allergy in 234 cases with allergic rhinitis and asthma].
    Li MR; Wang XN; Jiang HD; Wang QY; Li YC; Lin J; Jin K; Zhang HL; Li CC
    Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):726-31. PubMed ID: 23302557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of inhalant allergen immunotherapy with mass units-standardized extracts.
    Nettis E; Giordano D; Pannofino A; Ferrannini A; Tursi A
    Clin Exp Allergy; 2002 Dec; 32(12):1745-9. PubMed ID: 12653166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety of immunotherapy and skin tests with allergens in children younger than five years].
    Rodríguez Pérez N; Ambriz Moreno Mde J
    Rev Alerg Mex; 2006; 53(2):47-51. PubMed ID: 16884027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of rush immunotherapy to multiple aeroallergens in an adult population.
    Harvey SM; Laurie S; Hilton K; Khan DA
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):414-9. PubMed ID: 15104192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.
    Nolte H; Hébert J; Berman G; Gawchik S; White M; Kaur A; Liu N; Lumry W; Maloney J
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):450-456.e4. PubMed ID: 23706715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of rush immunotherapy using a modified schedule: a cumulative experience of 893 patients receiving multiple aeroallergens.
    Smits WL; Giese JK; Letz KL; Inglefield JT; Schlie AR
    Allergy Asthma Proc; 2007; 28(3):305-12. PubMed ID: 17619559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.